Discover 3,404 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Location: Los Angeles CA, La Jolla CA, Gilbert AZ, Seattle WA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06682793
Phase1, Phase2, Recruiting
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: Santa Monica CA, La Jolla CA, Palo Alto CA, Phoenix AZ,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: Los Angeles CA, La Jolla CA, Stanford CA, Gilbert AZ,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase1, Phase2, Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Santa Monica CA, El Segundo CA, Bakersfield CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: Los Angeles CA, Glendale CA, Montebello CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
for
Esophageal Squamous Cell Carcinoma
Location: Los Angeles CA, Tucson AZ, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05319730
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Santa Monica CA, Irving TX, St Louis MO, Jefferson LA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase1, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Los Angeles CA, Long Beach CA, Duarte CA, Orange CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Santa Monica CA, Glendale CA, Los Alamitos CA,